BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22882809)

  • 1. An informant questionnaire for detecting Alzheimer's disease: are some items better than others?
    Sikkes SA; Knol DL; van den Berg MT; de Lange-de Klerk ES; Scheltens P; Klein M; Pijnenburg YA; Uitdehaag BM
    J Int Neuropsychol Soc; 2011 Jul; 17(4):674-81. PubMed ID: 22882809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints?
    Sikkes SA; van den Berg MT; Knol DL; de Lange-de Klerk ES; Scheltens P; Uitdehaag BM; Klein M; Pijnenburg YA
    Dement Geriatr Cogn Disord; 2010; 30(5):411-6. PubMed ID: 21071942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment.
    Li F; Jia XF; Jia J
    J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):227-32. PubMed ID: 23172761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ryu SY; Lee SB; Kim TW; Lee TJ
    Acta Neurol Belg; 2016 Dec; 116(4):535-541. PubMed ID: 26861053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informant questionnaire on cognitive decline in the elderly (IQCODE) for assessing the severity of dementia in patients with Alzheimer's disease.
    Ding Y; Niu J; Zhang Y; Liu W; Zhou Y; Wei C; Liu Y
    BMC Geriatr; 2018 Jun; 18(1):146. PubMed ID: 29914396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment.
    Buckley R; Saling M; Ellis K; Rowe C; Maruff P; Macaulay LS; Martins R; Masters C; Savage G; Rainey-Smith S; Rembach A; Ames D
    Age Ageing; 2015 Nov; 44(6):1012-9. PubMed ID: 26452663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease.
    Ehrensperger MM; Berres M; Taylor KI; Monsch AU
    Int Psychogeriatr; 2010 Feb; 22(1):91-100. PubMed ID: 19747425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study.
    Rami L; Mollica MA; García-Sanchez C; Saldaña J; Sanchez B; Sala I; Valls-Pedret C; Castellví M; Olives J; Molinuevo JL
    J Alzheimers Dis; 2014; 41(2):453-66. PubMed ID: 24625794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A detection of very mild Alzheimer's disease and MCI by memory complaints and deterioration of IADL in a questionnaire for a memory clinic].
    Ueda M; Takayama Y; Koyama Y; Osada H
    No To Shinkei; 2006 Oct; 58(10):865-71. PubMed ID: 17087278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self- and informant-reported cognitive functioning and awareness in subjective cognitive decline, mild cognitive impairment, and very mild Alzheimer disease.
    Ryu SY; Kim A; Kim S; Park KW; Park KH; Youn YC; Lee DW; Lee JY; Lee JH; Jeong JH; Choi SH; Han HJ; Kim S; Na S; Park M; Yim HW; Yang DW
    Int J Geriatr Psychiatry; 2020 Jan; 35(1):91-98. PubMed ID: 31650618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE.
    Razavi M; Tolea MI; Margrett J; Martin P; Oakland A; Tscholl DW; Ghods S; Mina M; Galvin JE
    Alzheimer Dis Assoc Disord; 2014; 28(2):156-61. PubMed ID: 24113559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informant questionnaire on cognitive decline in the elderly (IQCODE) for classifying cognitive dysfunction as cognitively normal, mild cognitive impairment, and dementia.
    Park MH
    Int Psychogeriatr; 2017 Sep; 29(9):1461-1467. PubMed ID: 28560943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telephone screening for mild cognitive impairment in hispanics using the Alzheimer's questionnaire.
    Salazar R; Velez CE; Royall DR
    Exp Aging Res; 2014; 40(2):129-39. PubMed ID: 24625043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.
    Buckley R; Saling MM; Ames D; Rowe CC; Lautenschlager NT; Macaulay SL; Martins RN; Masters CL; O'Meara T; Savage G; Szoeke C; Villemagne VL; Ellis KA;
    Int Psychogeriatr; 2013 Aug; 25(8):1307-15. PubMed ID: 23693133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients with mild cognitive impairment.
    Bárrios H; Narciso S; Guerreiro M; Maroco J; Logsdon R; de Mendonça A
    Aging Ment Health; 2013; 17(3):287-92. PubMed ID: 23215827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective Cognitive Complaints: Comparing the Relation between Self-Reported Versus Informant-Reported Subjective Cognitive Complaints and Cognitive Performances in Cognitively Unimpaired, Mild Cognitive Impairment and Populations with Dementia.
    Peng SW; Wang CY; Lin SY; Lee YL; Lin YC; Lin YJ; Wang PN
    J Prev Alzheimers Dis; 2023; 10(3):562-570. PubMed ID: 37357298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing precision of the 16-item Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE-16) using Rasch methodology.
    Truong QC; Choo C; Numbers K; Merkin AG; Sachdev PS; Feigin VL; Brodaty H; Kochan NA; Medvedev ON
    Int Psychogeriatr; 2024 Mar; 36(3):166-176. PubMed ID: 34794521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease.
    Rami L; Bosch B; Sanchez-Valle R; Molinuevo JL
    Arch Gerontol Geriatr; 2010; 50(2):171-4. PubMed ID: 19375179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.